SCHEMBL2861587

SCHEMBL2861587

O=C(NC1CC1)c1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1F

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDR P35968 1/20 0.49
DYRK1A Q13627 11/20 0.42
WNT1 P04628 8/20 0.42
LRRK2 Q5S007 1/20 0.42
GSK3B P49841 2/20 0.41
KCNH2 Q12809 2/20 0.41
MAPK8 P45983 1/20 0.41
CHEK1 O14757 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MCHR1 Q99705 1/20 0.40
SMYD3 Q9H7B4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2866826 0.85 DYRK1A (0.52) KDRDYRK1AWNT1LRRK2GSK3B
SCHEMBL2864594 0.85 KDR (0.47) KDRDYRK1ALRRK2NPC1RAB9A
SCHEMBL2857443 0.82 CA12 (0.46) KDRMAPK8
SCHEMBL2867207 0.82 KDR (0.48) KDRDYRK1AWNT1GSK3BKCNH2
SCHEMBL4327031 0.82 MTNR1A (0.41) KDRDYRK1AWNT1NPC1RAB9A
SCHEMBL2864933 0.81 PIP5K1C (0.48) KDRDYRK1AWNT1LRRK2GSK3B
SCHEMBL2857326 0.81 PIP5K1C (0.48) KDRDYRK1AWNT1MAPK8CHEK1
SCHEMBL2867525 0.81 ALPL (0.50) KDR
Cyclopropanecarboxylic Acid Amide SCHEMBL2861585 0.80 NPC1 (0.40) KDRLRRK2GSK3BNPC1RAB9A
SCHEMBL4339304 0.79 SCN9A (0.39) KDRDYRK1AWNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDR 2411/4885DYRK1A 1216/4885WNT1 77/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 KDR 3273/4885DYRK1A 2459/4885WNT1 77/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDR 2411/4885DYRK1A 1216/4885WNT1 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.